Literature DB >> 34295379

Prevalence of multidrug-resistant bacteria colonisation among asylum seekers in western Switzerland.

Alain Kenfak-Foguena1, Immaculée Nahimana Tessemo2,3, Claire Bertelli4, Laurent Merz5, Alain Cometta5, Dominique Blanc3, Laurence Senn3, Christiane Petignat2,3.   

Abstract

The recent increase of migration to Europe represents a risk of increased the prevalence of multidrug-resistant (MDR) bacteria. We conducted a cross-sectional study among asylum seekers admitted at two hospitals in Switzerland. Of the 59 patients included, 9 (14%) were colonised by a MDR bacteria, including 5 (8.5%) methicilin-resistant Staphylococcus aureus (MRSA) and 4 (6.8%) extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. No patient carried both ESBL-producing bacteria and MRSA. None of the patients carried a vancomycin-resistant Enterococcus (VRE) or a carbapenem-resistant Enterobacteriaceae (CRE). Colonisation with MDR bacteria was not associated with hospitalisation abroad or recent arrival in Switzerland. Whole genome sequencing analysis allowed us to exclude transmission between patients. The prevalence of MDR bacteria carriage is moderate among asylum seekers in western Switzerland. Further surveillance studies are necessary to determine if there is a risk of dissemination of pathogens into the local population.
© The Author(s) 2021.

Entities:  

Keywords:  Europe; Multidrug-resistant bacteria; Switzerland; asylum seekers; carbapenem-resistant Enterobacteriaceae; extended-spectrum beta-lactamases producing Enterobacteriaceae; methicilin-resistant Staphylococcus aureus; vancomycin-resistant Enterococcus

Year:  2021        PMID: 34295379      PMCID: PMC8274134          DOI: 10.1177/1757177420982033

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  9 in total

Review 1.  Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology.

Authors:  Antony Croxatto; Guy Prod'hom; Gilbert Greub
Journal:  FEMS Microbiol Rev       Date:  2011-08-22       Impact factor: 16.408

2.  ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.

Authors:  Aurélien Emmanuel Martinez; Andreas Widmer; Reno Frei; Hans Pargger; Daniel Tuchscherer; Stephan Marsch; Adrian Egli; Sarah Tschudin-Sutter
Journal:  Infect Control Hosp Epidemiol       Date:  2019-02-21       Impact factor: 3.254

3.  Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients.

Authors:  Stephan Harbarth; Carolina Fankhauser; Jacques Schrenzel; Jan Christenson; Pascal Gervaz; Catherine Bandiera-Clerc; Gesuele Renzi; Nathalie Vernaz; Hugo Sax; Didier Pittet
Journal:  JAMA       Date:  2008-03-12       Impact factor: 56.272

4.  Community-associated methicillin-resistant Staphylococcus aureus, Switzerland.

Authors:  Stephan Harbarth; Patrice François; Jacques Shrenzel; Carolina Fankhauser-Rodriguez; Stephane Hugonnet; Thibaud Koessler; Antoine Huyghe; Didier Pittet
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

5.  A Cross-Sectional Study of Colonization Rates with Methicillin-Resistant Staphylococcus aureus (MRSA) and Extended-Spectrum Beta-Lactamase (ESBL) and Carbapenemase-Producing Enterobacteriaceae in Four Swiss Refugee Centres.

Authors:  Rein Jan Piso; Roman Käch; Roxana Pop; Daniela Zillig; Urs Schibli; Stefano Bassetti; Dominik Meinel; Adrian Egli
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

6.  Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review.

Authors:  R Fulchini; W C Albrich; A Kronenberg; A Egli; C R Kahlert; M Schlegel; P Kohler
Journal:  Epidemiol Infect       Date:  2019-08-30       Impact factor: 2.451

7.  Methicillin-resistant Staphylococcus aureus risk profiling: who are we missing?

Authors:  Janet Pasricha; Stephan Harbarth; Thibaud Koessler; Veronique Camus; Jacques Schrenzel; Gilles Cohen; Didier Pittet; Arnaud Perrier; Anne Iten
Journal:  Antimicrob Resist Infect Control       Date:  2013-05-30       Impact factor: 4.887

8.  Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland.

Authors:  Janet Pasricha; Thibaud Koessler; Stephan Harbarth; Jacques Schrenzel; Véronique Camus; Gilles Cohen; Arnaud Perrier; Didier Pittet; Anne Iten
Journal:  Antimicrob Resist Infect Control       Date:  2013-06-12       Impact factor: 4.887

9.  Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.

Authors:  Laura B Nellums; Hayley Thompson; Alison Holmes; Enrique Castro-Sánchez; Jonathan A Otter; Marie Norredam; Jon S Friedland; Sally Hargreaves
Journal:  Lancet Infect Dis       Date:  2018-05-17       Impact factor: 71.421

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.